Lagoda-backed holder files Schedule 13D after 7.4% VolitionRx stake
Fatima Dickey, via Lagoda Investment Management, disclosed a 7.4% stake in VolitionRx. The holder switched from a passive Schedule 13G to an active Schedule 13D filed September 4, 2026.
Fatima Dickey, through Lagoda Investment Management, disclosed a 7.4% stake in VolitionRx Limited.
The group switched from a passive Schedule 13G to an active Schedule 13D filed on September 4, 2026.
The move signals an effort to influence costs while supporting the company’s strategy.Investor Inte…